Sort
23,748 grants matching “melanoma”
Bevacizumab plus Ipilimumab in Unresectable Stage III or Stage IV Melanoma
$332,407Frank S Hodi · Dana-Farber Cancer Inst · R21 · FY2010 · CA
Role of Polo-Like Kinase-1 in Melanocytic Transformation
$332,379Nihal Ahmad · University Of Wisconsin-Madison · R01 · FY2010 · AR
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
$332,363Glen N. Barber · University Of Miami School Of Medicine · R01 · FY2015 · CA
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
$332,363Glen N. Barber · University Of Miami School Of Medicine · R01 · FY2016 · CA
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
$332,363Glen N. Barber · University Of Miami School Of Medicine · R01 · FY2017 · CA
HLTF gene silencing: a novel determinant of sensitivity to autophagy inhibition
$332,350Ravi K Amaravadi · University Of Pennsylvania · R01 · FY2014 · CA
Engineering of computational receptors and gene circuits for T-cell immunotherapy
$332,333Yvonne Yu-Hsuan Chen · University Of California Los Angeles · DP5 · FY2013 · OD
Project 4-Modulating Innate Immunity to Overcome Resistance to PD-1/PD-L1 Blockade
$332,308Harriet M Kluger · Yale University · P50 · FY2021 · CA
Project 4-Modulating Innate Immunity to Overcome Resistance to PD-1/PD-L1 Blockade
$332,297Harriet M Kluger · Yale University · P50 · FY2019 · CA
MOLECULAR MECHANISMS IN METASTASIS--ROLE OF FIBRONECTIN
$332,248University Of Minnesota Twin Cities · R01 · FY2000 · CA
Biospecimen Core/Immunologic Monitoring and Cellular Products Laboratory
$332,228Lisa Helene Butterfield · University Of Pittsburgh At Pittsburgh · P50 · FY2013 · CA
Targeting HSP70 in autoimmune vitiligo
$332,200Isabelle Caroline Le Poole · Loyola University Chicago · R56 · FY2014 · AR
MI--A MASTER GENE FOR MELANOCYTE DEVELOPMENT
$332,120Dana-Farber Cancer Institute · R01 · FY2002 · AR
Core B: Biospecimen Repository and Processing Core
$332,084Begonya Comin-Anduix · University Of California Los Angeles · P01 · FY2024 · CA
Intracerebrally delivered EGFRvIII-targeted CARs for brain tumors
$332,072John H Sampson · Duke University · P50 · FY2015 · CA
The role of the PI3K pathway in immune resistance
$332,000Patrick Hwu · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA
Understanding Wnt5a regulation of protein depalmitoylation during cell migration
$332,000Eric S. Witze · University Of Pennsylvania · R01 · FY2016 · CA
Regulation of a DNA damage response network in glioblastoma
$332,000Andy J Minn · University Of Pennsylvania · R01 · FY2017 · CA
Tumor antigen-specific T-cells and hepatocellular carcinoma
$332,000David E Kaplan · University Of Pennsylvania · R01 · FY2016 · CA
(PQ #4) Single cell barcoding for studies of study clonal evolution in glioblasto
$332,000Roel Gw Verhaak · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA
Regulation of a DNA damage response network in glioblastoma
$332,000Andy J Minn · University Of Pennsylvania · R01 · FY2015 · CA
Combined CD40 activation and CTLA4 blockade in melanoma
$332,000Robert H Vonderheide · University Of Pennsylvania · R01 · FY2015 · CA
Combined CD40 activation and CTLA4 blockade in melanoma
$332,000Robert H Vonderheide · University Of Pennsylvania · R01 · FY2011 · CA
Tumor antigen-specific T-cells and hepatocellular carcinoma
$332,000David E Kaplan · University Of Pennsylvania · R01 · FY2015 · CA
The role of the PI3K pathway in immune resistance
$332,000Patrick Hwu · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA